MSeqDR Mitochondrial Disease Portal


 
*:HP: HPO terms, UMDF: 1= Disease, ND: NAMDC terms.
  Most Studied  CPEO, Complex I Deficiency, COXPD1, Leigh, LHON, MELAS, MERRF, Myopathy, SANDO
Disease Browser
Parent Node:
expand
Neoplastic Syndromes, Hereditary (D009386)
Parent Node:
expand
Paraganglioma (D010235)
..Starting node
..expand
Paragangliomas 2 (C566646)

       Child Nodes:



 Sister Nodes: 
..expandCarney-Stratakis Syndrome (C564650)
..expandParaganglioma, Extra-Adrenal (D010236) Child6
..expandParagangliomas 2 (C566646)
..expandParagangliomas 3 (C565335)
..expandPARAGANGLIOMAS 4 (OMIM:115310)
..expandPARAGANGLIOMAS 5 (OMIM:614165)
..expandParagangliomas with Sensorineural Hearing Loss (C566831)
..expandPheochromocytoma (D010673) Child2
   

Human Disease MESH is developed by UMLS.
Further data from MedGen, OMIM,ClinVar, CTD
Term ID:9480
Name:Paragangliomas 2
Definition:
Alternative IDs:OMIM:601650
ParentIDs:MESH:D009386|MESH:D010235
TreeNumbers:C04.557.465.625.650.700/C566646 |C04.557.580.625.650.700/C566646 |C04.700/C566646 |C16.320.700/C566646
Synonyms:Glomus Tumors, Familial, 2 |PGL2
Slim Mappings:Cancer|Genetic disease (inborn)
Reference: MedGen: C566646
MeSH: C566646
OMIM: 601650;
MSeqDR LSDB:  
Genes: SDHAF2;
Phenotypes
1 HP:0000006Autosomal dominant inheritance
2 HP:0003581Adult onset
3 HP:0030074Chemodectoma
4 HP:0006824Cranial nerve paralysis
5 HP:0003001Glomus jugular tumor
6 HP:0006715Glomus tympanicum paraganglioma
7 HP:0001609Hoarse voice
8 HP:0001686Loss of voice
9 HP:0008629Pulsatile tinnitus
10 HP:0002886Vagal paraganglioma
11 HP:0001605Vocal cord paralysis
Disease Causing ClinVar Variants
Variation_NameGeneIDGeneSymbolClinicalSignificancedbSNPRCVaccessionTestedInGTRPhenotypeIDsChromosomeStartStopHGVS_cHGVS_pHGVS_gOtherIDsDisease_ClinVar
NM_017841.4(SDHAF2):c.5C>A (p.Ala2Glu)54949SDHAF2Uncertain significance-1RCV003472632; NMONDO:MONDO:0011121,MedGen:C1866552,OMIM:601650, Orphanet:29072116119762361197623-
NM_017841.4(SDHAF2):c.11C>G (p.Ser4Cys)54949SDHAF2Uncertain significance778449586RCV000801877|RCV001010273|RCV003472368; NMONDO:MONDO:0017366,MedGen:C1708353, Orphanet:29072|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0011121,MedGen:C1866552,OMIM:601650, Orphanet:2907211611976296119762911:g.61197629C>G-
NM_017841.4(SDHAF2):c.25A>G (p.Thr9Ala)54949SDHAF2Conflicting interpretations of pathogenicity1554983610RCV000547322|RCV002255443|RCV003476258; NMONDO:MONDO:0017366,MedGen:C1708353, Orphanet:29072|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0011121,MedGen:C1866552,OMIM:601650, Orphanet:2907211611976436119764311:g.61197643A>GClinGen:CA380680194C1708353 Hereditary Paraganglioma-Pheochromocytoma Syndromes;
NM_017841.4(SDHAF2):c.32C>T (p.Ser11Leu)54949SDHAF2Likely benign148425779RCV000540123|RCV000567200|RCV001530643|RCV002497118; NMONDO:MONDO:0017366,MedGen:C1708353, Orphanet:29072|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0011121,MedGen:C1866552,OMIM:601650, Orphanet:2907211611976506119765011:g.61197650C>TClinGen:CA058473C0027672 Hereditary cancer-predisposing syndrome;
NM_017841.4(SDHAF2):c.36G>T (p.Leu12=)54949SDHAF2Uncertain significance-1RCV002790668|RCV003375693|RCV003475422; NMONDO:MONDO:0017366,MedGen:C1708353, Orphanet:29072|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0011121,MedGen:C1866552,OMIM:601650, Orphanet:29072116119765461197654-
NM_017841.4(SDHAF2):c.36+10G>A54949SDHAF2Benign/Likely benign114207859RCV000228443|RCV000254091|RCV002500807; NMONDO:MONDO:0017366,MedGen:C1708353, Orphanet:29072|MedGen:CN169374|MONDO:MONDO:0011121,MedGen:C1866552,OMIM:601650, Orphanet:2907211611976646119766411:g.61197664G>AClinGen:CA058576C1708353 Hereditary Paraganglioma-Pheochromocytoma Syndromes;
NM_017841.4(SDHAF2):c.37-1G>C54949SDHAF2Pathogenic/Likely pathogenic761956866RCV000994638|RCV001238114|RCV001784526|RCV002346199; NMedGen:C3661900|MONDO:MONDO:0017366,MedGen:C1708353, Orphanet:29072|MONDO:MONDO:0011121,MedGen:C1866552,OMIM:601650, Orphanet:29072|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:14016211612050966120509611:g.61205096G>C-
NM_017841.4(SDHAF2):c.42_45del (p.Ala15fs)54949SDHAF2Likely pathogenic1862009020RCV001262451; NMONDO:MONDO:0011121,MedGen:C1866552,OMIM:601650, Orphanet:2907211612050986120510111:g.61205098_61205101del-
NM_017841.4(SDHAF2):c.39G>C (p.Met13Ile)54949SDHAF2Uncertain significance-1RCV003472633; NMONDO:MONDO:0011121,MedGen:C1866552,OMIM:601650, Orphanet:29072116120509961205099-
NM_017841.4(SDHAF2):c.52A>G (p.Arg18Gly)54949SDHAF2Uncertain significance200911550RCV000034763|RCV000568645|RCV000687293|RCV003473261; NMedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0017366,MedGen:C1708353, Orphanet:29072|MONDO:MONDO:0011121,MedGen:C1866552,OMIM:601650, Orphanet:2907211612051126120511211:g.61205112A>GClinGen:CA017332C0027672 Hereditary cancer-predisposing syndrome;
NM_017841.4(SDHAF2):c.71C>T (p.Pro24Leu)54949SDHAF2Uncertain significance-1RCV003472631; NMONDO:MONDO:0011121,MedGen:C1866552,OMIM:601650, Orphanet:29072116120513161205131-
NM_017841.4(SDHAF2):c.96A>T (p.Arg32Ser)54949SDHAF2Uncertain significance952830677RCV001223024|RCV003163731|RCV003473778; NMONDO:MONDO:0017366,MedGen:C1708353, Orphanet:29072|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0011121,MedGen:C1866552,OMIM:601650, Orphanet:2907211612051566120515611:g.61205156A>T-
NM_017841.4(SDHAF2):c.139A>G (p.Met47Val)54949SDHAF2Uncertain significance111402137RCV000566506|RCV000703323|RCV003471907; NMONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0017366,MedGen:C1708353, Orphanet:29072|MONDO:MONDO:0011121,MedGen:C1866552,OMIM:601650, Orphanet:2907211612051996120519911:g.61205199A>GClinGen:CA057795C0027672 Hereditary cancer-predisposing syndrome;
NM_017841.4(SDHAF2):c.173G>A (p.Arg58Lys)54949SDHAF2Uncertain significance-1RCV003472634; NMONDO:MONDO:0011121,MedGen:C1866552,OMIM:601650, Orphanet:29072116120523361205233-
NM_017841.4(SDHAF2):c.196A>G (p.Lys66Glu)54949SDHAF2Uncertain significance371977724RCV001909973|RCV002423019|RCV003318701|RCV003475162; NMONDO:MONDO:0017366,MedGen:C1708353, Orphanet:29072|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0011121,MedGen:C1866552,OMIM:601650, Orphanet:2907211612052566120525661205256-
NM_017841.4(SDHAF2):c.199A>G (p.Arg67Gly)54949SDHAF2Uncertain significance1862011610RCV002026347|RCV002423263|RCV003475291; NMONDO:MONDO:0017366,MedGen:C1708353, Orphanet:29072|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0011121,MedGen:C1866552,OMIM:601650, Orphanet:2907211612052596120525961205259-
NM_017841.4(SDHAF2):c.205C>T (p.Arg69Cys)54949SDHAF2Uncertain significance532255760RCV000219985|RCV000468611|RCV002298531|RCV003444221; NMONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0017366,MedGen:C1708353, Orphanet:29072|MedGen:C3661900|MONDO:MONDO:0011121,MedGen:C1866552,OMIM:601650, Orphanet:2907211612052656120526511:g.61205265C>TClinGen:CA057946C0027672 Hereditary cancer-predisposing syndrome;
NM_017841.4(SDHAF2):c.206G>A (p.Arg69His)54949SDHAF2Uncertain significance753474292RCV000222477|RCV000792983|RCV001800552|RCV002503868; NMONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0017366,MedGen:C1708353, Orphanet:29072|MedGen:CN169374|MONDO:MONDO:0011121,MedGen:C1866552,OMIM:601650, Orphanet:2907211612052666120526611:g.61205266G>AClinGen:CA057958C0027672 Hereditary cancer-predisposing syndrome;
NM_017841.4(SDHAF2):c.221G>A (p.Ser74Asn)54949SDHAF2Uncertain significance1060503389RCV000472498|RCV000573339|RCV003476103; NMONDO:MONDO:0017366,MedGen:C1708353, Orphanet:29072|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0011121,MedGen:C1866552,OMIM:601650, Orphanet:29072116120528161205281NC_000011.9:g.61205281G>AClinGen:CA16613651C0027672 Hereditary cancer-predisposing syndrome;
NM_017841.4(SDHAF2):c.229_230del (p.Arg77fs)54949SDHAF2Pathogenic/Likely pathogenic1336819076RCV001999776|RCV003475212; NMONDO:MONDO:0017366,MedGen:C1708353, Orphanet:29072|MONDO:MONDO:0011121,MedGen:C1866552,OMIM:601650, Orphanet:2907211612052876120528861205286-
NM_017841.4(SDHAF2):c.232G>A (p.Gly78Arg)54949SDHAF2Pathogenic113560320RCV000000428|RCV000165971|RCV000519058|RCV000639339; NMONDO:MONDO:0011121,MedGen:C1866552,OMIM:601650, Orphanet:29072|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0017366,MedGen:C1708353, Orphanet:2907211612052926120529211:g.61205292G>AClinGen:CA017320,UniProtKB:Q9NX18#VAR_058705,OMIM:613019.0001C0027672 Hereditary cancer-predisposing syndrome;
NM_017841.4(SDHAF2):c.232G>C (p.Gly78Arg)54949SDHAF2not provided-1RCV003319153; NMONDO:MONDO:0011121,MedGen:C1866552,OMIM:601650, Orphanet:29072116120529261205292-
NM_017841.4(SDHAF2):c.235A>G (p.Met79Val)54949SDHAF2Uncertain significance781702725RCV001015284|RCV001211466|RCV003473576; NMONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0017366,MedGen:C1708353, Orphanet:29072|MONDO:MONDO:0011121,MedGen:C1866552,OMIM:601650, Orphanet:2907211612052956120529511:g.61205295A>G-
NM_017841.4(SDHAF2):c.260+3A>G54949SDHAF2Conflicting interpretations of pathogenicity1445986287RCV000571706|RCV001035689|RCV003471908; NMONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0017366,MedGen:C1708353, Orphanet:29072|MONDO:MONDO:0011121,MedGen:C1866552,OMIM:601650, Orphanet:2907211612053236120532311:g.61205323A>GClinGen:CA658658063C0027672 Hereditary cancer-predisposing syndrome;
NM_017841.4(SDHAF2):c.261-42G>A54949SDHAF2Benign879647RCV000248502|RCV001651225|RCV001807190; NMedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0011121,MedGen:C1866552,OMIM:601650, Orphanet:29072116120543461205434NC_000011.9:g.61205434G>AClinGen:CA058276CN169374 not specified;
NM_017841.4(SDHAF2):c.301C>T (p.Gln101Ter)54949SDHAF2Likely pathogenic-1RCV003472635; NMONDO:MONDO:0011121,MedGen:C1866552,OMIM:601650, Orphanet:29072116120551661205516-
NM_017841.4(SDHAF2):c.305_306insA (p.Asn103fs)54949SDHAF2Conflicting interpretations of pathogenicity753554501RCV000639336|RCV001018326|RCV001766368|RCV003472006; NMONDO:MONDO:0017366,MedGen:C1708353, Orphanet:29072|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0011121,MedGen:C1866552,OMIM:601650, Orphanet:29072116120552061205521NC_000011.9:g.61205520_61205521insAClinGen:CA058404C1708353 Hereditary Paraganglioma-Pheochromocytoma Syndromes;
NM_017841.4(SDHAF2):c.313T>A (p.Tyr105Asn)54949SDHAF2Uncertain significance1485358364RCV000556172|RCV002323960|RCV003476259; NMONDO:MONDO:0017366,MedGen:C1708353, Orphanet:29072|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0011121,MedGen:C1866552,OMIM:601650, Orphanet:2907211612055286120552811:g.61205528T>AClinGen:CA380684128C1708353 Hereditary Paraganglioma-Pheochromocytoma Syndromes;
NM_017841.4(SDHAF2):c.320G>A (p.Arg107His)54949SDHAF2Conflicting interpretations of pathogenicity535627239RCV000529961|RCV001019240|RCV003153704|RCV003476260; NMONDO:MONDO:0017366,MedGen:C1708353, Orphanet:29072|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0008170,MedGen:C1140680, Orphanet:213500|MONDO:MONDO:0011121,MedGen:C1866552,OMIM:601650, Orphanet:2907211612055356120553511:g.61205535G>AClinGen:CA058449C1708353 Hereditary Paraganglioma-Pheochromocytoma Syndromes;
NM_017841.4(SDHAF2):c.330C>A (p.Asn110Lys)54949SDHAF2Uncertain significance779335034RCV000700336|RCV001019853|RCV002509360|RCV003475930; NMONDO:MONDO:0017366,MedGen:C1708353, Orphanet:29072|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0011121,MedGen:C1866552,OMIM:601650, Orphanet:29072116120554561205545NC_000011.9:g.61205545C>AClinGen:CA10638833C1708353 Hereditary Paraganglioma-Pheochromocytoma Syndromes;
NM_017841.4(SDHAF2):c.331G>A (p.Glu111Lys)54949SDHAF2Uncertain significance145616631RCV000461728|RCV001019980|RCV003476105; NMONDO:MONDO:0017366,MedGen:C1708353, Orphanet:29072|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0011121,MedGen:C1866552,OMIM:601650, Orphanet:29072116120554661205546NC_000011.9:g.61205546G>AClinGen:CA058486C1708353 Hereditary Paraganglioma-Pheochromocytoma Syndromes;
NM_017841.4(SDHAF2):c.341A>G (p.Asn114Ser)54949SDHAF2Conflicting interpretations of pathogenicity747022200RCV000697271|RCV003472224|RCV003153814; NMONDO:MONDO:0017366,MedGen:C1708353, Orphanet:29072|MONDO:MONDO:0011121,MedGen:C1866552,OMIM:601650, Orphanet:29072|MONDO:MONDO:0008170,MedGen:C1140680, Orphanet:213500116120555661205556NC_000011.9:g.61205556A>G-C1708353 Hereditary Paraganglioma-Pheochromocytoma Syndromes;
NM_017841.4(SDHAF2):c.355dup (p.Tyr119fs)54949SDHAF2Conflicting interpretations of pathogenicity1456129845RCV000456060|RCV000639340|RCV002451059|RCV003476021; NMedGen:CN169374|MONDO:MONDO:0017366,MedGen:C1708353, Orphanet:29072|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0011121,MedGen:C1866552,OMIM:601650, Orphanet:29072116120556761205568NC_000011.9:g.61205570dupClinGen:CA16609799C1708353 Hereditary Paraganglioma-Pheochromocytoma Syndromes;
NM_017841.4(SDHAF2):c.352A>G (p.Ile118Val)54949SDHAF2Uncertain significance747994812RCV001020532|RCV001067015|RCV001253131; NMONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0017366,MedGen:C1708353, Orphanet:29072|MONDO:MONDO:0011121,MedGen:C1866552,OMIM:601650, Orphanet:2907211612055676120556711:g.61205567A>G-
NM_017841.4(SDHAF2):c.370+4C>G54949SDHAF2Uncertain significance758935566RCV000792882|RCV002487647; NMONDO:MONDO:0017366,MedGen:C1708353, Orphanet:29072|MONDO:MONDO:0011121,MedGen:C1866552,OMIM:601650, Orphanet:2907211612055896120558911:g.61205589C>G-
NM_017841.4(SDHAF2):c.371-4G>C54949SDHAF2Uncertain significance-1RCV003472636; NMONDO:MONDO:0011121,MedGen:C1866552,OMIM:601650, Orphanet:29072116121340961213409-
NM_017841.4(SDHAF2):c.371-2A>G54949SDHAF2Conflicting interpretations of pathogenicity375280597RCV000467864|RCV000566130|RCV003476104; NMONDO:MONDO:0017366,MedGen:C1708353, Orphanet:29072|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0011121,MedGen:C1866552,OMIM:601650, Orphanet:29072116121341161213411NC_000011.9:g.61213411A>GClinGen:CA059030C0027672 Hereditary cancer-predisposing syndrome;
NM_017841.4(SDHAF2):c.391A>T (p.Ile131Leu)54949SDHAF2Uncertain significance773580529RCV000639348|RCV002358808|RCV003472008; NMONDO:MONDO:0017366,MedGen:C1708353, Orphanet:29072|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0011121,MedGen:C1866552,OMIM:601650, Orphanet:2907211612134336121343311:g.61213433A>TClinGen:CA059240C1708353 Hereditary Paraganglioma-Pheochromocytoma Syndromes;
NM_017841.4(SDHAF2):c.410T>A (p.Met137Lys)54949SDHAF2Uncertain significance367574730RCV000807160|RCV003472392|RCV003380735; NMONDO:MONDO:0017366,MedGen:C1708353, Orphanet:29072|MONDO:MONDO:0011121,MedGen:C1866552,OMIM:601650, Orphanet:29072|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:14016211612134526121345211:g.61213452T>A-
NM_017841.4(SDHAF2):c.454A>G (p.Arg152Gly)54949SDHAF2Uncertain significance1056273933RCV001947703|RCV002334886|RCV003475166; NMONDO:MONDO:0017366,MedGen:C1708353, Orphanet:29072|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0011121,MedGen:C1866552,OMIM:601650, Orphanet:2907211612134966121349661213496-
NM_017841.4(SDHAF2):c.476A>C (p.Glu159Ala)54949SDHAF2Uncertain significance140920079RCV000477172|RCV000574855|RCV002291637|RCV003148750; NMONDO:MONDO:0017366,MedGen:C1708353, Orphanet:29072|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0011121,MedGen:C1866552,OMIM:601650, Orphanet:29072|MedGen:C3661900116121351861213518NC_000011.9:g.61213518A>CClinGen:CA059412C0027672 Hereditary cancer-predisposing syndrome;
NM_017841.4(SDHAF2):c.479_482del (p.Tyr160fs)54949SDHAF2Uncertain significance-1RCV003140419; NMONDO:MONDO:0011121,MedGen:C1866552,OMIM:601650, Orphanet:29072116121352061213523NC_000011.9:g.61213521_61213524del-
NM_017841.4(SDHAF2):c.490A>G (p.Lys164Glu)54949SDHAF2Uncertain significance150187184RCV000232071|RCV002347911|RCV003322764|RCV003475832; NMONDO:MONDO:0017366,MedGen:C1708353, Orphanet:29072|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0011121,MedGen:C1866552,OMIM:601650, Orphanet:29072116121353261213532NC_000011.9:g.61213532A>GClinGen:CA059431C1708353 Hereditary Paraganglioma-Pheochromocytoma Syndromes;
NM_017841.4(SDHAF2):c.497G>A (p.Arg166His)54949SDHAF2Conflicting interpretations of pathogenicity768048172RCV000543075|RCV002341319|RCV002497119; NMONDO:MONDO:0017366,MedGen:C1708353, Orphanet:29072|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672, Orphanet:140162|MONDO:MONDO:0011121,MedGen:C1866552,OMIM:601650, Orphanet:2907211612135396121353911:g.61213539G>AClinGen:CA059440C1708353 Hereditary Paraganglioma-Pheochromocytoma Syndromes;
MSeqDR Portal